Serum Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Acute Respiratory Distress Syndrome: A Prospective Observational Cohort Study
暂无分享,去创建一个
Chong-Jen Yu | Chao-Chi Ho | Ming-Terz Lin | S. Ku | Yu Wei | Chih-An Lin | Chih‐An Lin
[1] M. Nojomi,et al. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis. , 2010, Journal of critical care.
[2] E. Martin,et al. Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation , 2009, European journal of anaesthesiology.
[3] H. Fisher,et al. Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort , 2009, Critical care.
[4] J. Craig,et al. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis* , 2009, Critical care medicine.
[5] A. Verbon,et al. Soluble Triggering Receptor Expressed on Myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia , 2009, Intensive Care Medicine.
[6] M. Kollef,et al. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. , 2009, Chest.
[7] H. Fisher,et al. Use of drotrecogin alfa (activated) in a severe acute respiratory syndrome patient with severe sepsis. , 2008, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.
[8] Hsuan-Yu Chen,et al. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. , 2008, American journal of respiratory and critical care medicine.
[9] E. Karapanagiotou,et al. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies. , 2008, Anticancer research.
[10] E. Giamarellos‐Bourboulis,et al. Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease. , 2007, World journal of gastroenterology.
[11] L. Nace,et al. Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis , 2007, Scandinavian journal of infectious diseases.
[12] I. Wakabayashi,et al. [Alcohol abuse as a risk factor for ARDS]. , 2006, Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence.
[13] E. Giamarellos‐Bourboulis,et al. Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease , 2006, European journal of gastroenterology & hepatology.
[14] H. Kondo,et al. Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystals. , 2006, Arthritis and rheumatism.
[15] A. Isibasi,et al. Expression of triggering receptor on myeloid cell 1 and histocompatibility complex molecules in sepsis and major abdominal surgery. , 2005, World journal of gastroenterology.
[16] J. Korevaar,et al. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia , 2005, Intensive Care Medicine.
[17] G. Rubenfeld,et al. Causes and timing of death in patients with ARDS. , 2005, Chest.
[18] S. Gibot. Clinical review: Role of triggering receptor expressed on myeloid cells-1 during sepsis , 2005, Critical care.
[19] M. Béné,et al. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis , 2005, Critical care medicine.
[20] G. Bernard,et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury* , 2005, Critical care medicine.
[21] P. Parsons,et al. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. , 2004, American journal of respiratory and critical care medicine.
[22] Manoj-Kumar Gupta,et al. Expression of TREM-1 mRNA in acute pancreatitis. , 2004, World journal of gastroenterology.
[23] L. Fabbri,et al. Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections , 2004, European Respiratory Journal.
[24] S. Gibot,et al. Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. , 2004, Clinical medicine & research.
[25] P. Bollaert,et al. Plasma Level of a Triggering Receptor Expressed on Myeloid Cells-1: Its Diagnostic Accuracy in Patients with Suspected Sepsis , 2004, Annals of Internal Medicine.
[26] Mitchell M. Levy,et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.
[27] M. Béné,et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. , 2004, The New England journal of medicine.
[28] M. Colonna,et al. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. , 2003, The Journal of infectious diseases.
[29] J. Vincent,et al. Epidemiology and outcome of acute respiratory failure in intensive care unit patients , 2003, Critical care medicine.
[30] Mitchell M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.
[31] M. Colonna,et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.
[32] M. Colonna,et al. Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1 , 2000, The Journal of Immunology.
[33] F. Brunkhorst,et al. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. , 1999, Critical care medicine.
[34] R. Strieter,et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.
[35] M. Matthay,et al. Identification of patients with acute lung injury. Predictors of mortality. , 1995, American journal of respiratory and critical care medicine.
[36] R. Maunder,et al. Clinical risks for development of the acute respiratory distress syndrome. , 1995, American journal of respiratory and critical care medicine.
[37] M. Lamy,et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.